MARY BROWN: Open Payments
NPI 1558866806 · BELPRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$181 in 9 payments from 6 companies in 2025. Trend: 2023 $243 · 2024 $300 · 2025 $181
Food & beverage: $181
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $41 |
| ABBVIE INC. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| Exact Sciences Corporation | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $23 |
Products named: ICLUSIG, CAPLYTA, Cologuard Collection Kit, Wegovy, TRELEGY ELLIPTA, QULIPTA, UBRELVY, Ozempic.
Industry payments across OH — which companies pay providers there.
